Literature DB >> 16252612

Neurological manifestations in severe acute respiratory syndrome.

Li-Kai Tsai1, Sung-Tsang Hsieh, Yang-Chyuan Chang.   

Abstract

During the worldwide outbreak of severe acute respiratory syndrome (SARS) in 2002-2003, there were 664 probable SARS patients reported in Taiwan. SARS patients usually present with symptoms related to the respiratory system while neurological manifestations have rarely been described. There were three patients who developed axonopathic polyneuropathy 3-4 weeks after onset of SARS; their clinical condition and electrophysiological studies revealed obvious improvement at follow-up. Two SARS patients have experienced myopathy and three other patients developed rhabdomyolysis. These neuromuscular disorders in SARS patients were considered as critical illness neuropathy and myopathy, but the possibility of direct attack by SARS coronavirus on the nerve and muscle could not be excluded. Large artery ischemic stroke were described in five SARS patients with poor prognosis. Multiple factors contributed to this vascular insult included hypercoagulabe status related to both SARS coronavirous and the usage of intravenous immunoglobulin, septic and cardiogenic shock, and possible vasculitis. The relationship between SARS and above neurological problems still needs further clarification. Pathological and microbiological studies are mandatory to delineate this issue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252612

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  105 in total

Review 1.  Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.

Authors:  Ayşe Nur Özdağ Acarli; Bedia Samanci; Esme Ekizoğlu; Arman Çakar; Nermin Görkem Şirin; Tuncay Gündüz; Yeşim Parman; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2020-05-01       Impact factor: 1.339

2.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43.

Authors:  Mathieu Dubé; Alain Le Coupanec; Alan H M Wong; James M Rini; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations.

Authors:  Margarita V Revzin; Sarah Raza; Neil C Srivastava; Robin Warshawsky; Catherine D'Agostino; Ajay Malhotra; Anna S Bader; Ritesh D Patel; Kan Chen; Christopher Kyriakakos; John S Pellerito
Journal:  Radiographics       Date:  2020 Nov-Dec       Impact factor: 5.333

4.  COVID-19 Pandemic: The Concerns of Pediatric Neurologists.

Authors:  Arushi G Saini; Renu Suthar
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

5.  The long-term consequences of Corona Virus Disease 2019 patients receiving Chinese herbal medicine treatments in acute phase: A protocol for systematic review and meta-analysis.

Authors:  Yi-Ming Sun; Jia-Yan Liu; Ran Sun; Jie Zhang; Meng-Lu Xiao; Gui-Ping Li
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

6.  Skeletal Muscle Manifestations and Creatine Kinase in COVID-19.

Authors:  Sarah A Friedman; Zeinab Charmchi; Michael Silver; Nuri Jacoby; Jonathan Perk; Yaacov Anziska
Journal:  Neurohospitalist       Date:  2022-06-01

Review 7.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

Review 8.  Potential Neurologic Manifestations of COVID-19.

Authors:  Anna S Nordvig; Kathryn T Fong; Joshua Z Willey; Kiran T Thakur; Amelia K Boehme; Wendy S Vargas; Craig J Smith; Mitchell S V Elkind
Journal:  Neurol Clin Pract       Date:  2021-04

Review 9.  A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Authors:  Baila Shakaib; Tanzeel Zohra; Aamer Ikram; Muhammad Bin Shakaib; Amna Ali; Adnan Bashir; Muhammad Salman; Mumtaz Ali Khan; Jamil Ansari
Journal:  Virol J       Date:  2021-06-07       Impact factor: 4.099

10.  Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.

Authors:  Yen-Hung Wu; I-Jeng Yeh; Nam Nhut Phan; Meng-Chi Yen; Jui-Hsiang Hung; Chung-Chieh Chiao; Chien-Fu Chen; Zhengda Sun; Hui-Ping Hsu; Chih-Yang Wang; Ming-Derg Lai
Journal:  J Microbiol Immunol Infect       Date:  2021-03-26       Impact factor: 4.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.